studies

2025/2027 Advanced Olympic Research Grants awarded

14 July 2025 - In the framework of the eleventh edition of the Advanced Olympic Research Grant Programme, the IOC Olympic Studies…

7 days ago

Medidata and the University of Sydney’s NHMRC Clinical Trials Centre Broaden Efforts to Revolutionize Clinical Studies in Australia

Continuing collaboration will utilize the capabilities of the Medidata Data Experience, fostering efficiency, fast-tracking research breakthroughs, and raising the standard…

2 weeks ago

The Olympic Studies Centre welcomes Moroccan National Olympic Committee as second partner of Olympic World Library Network

07 July 2025 – The Moroccan National Olympic Committee (CNOM) has become the second international partner of the Olympic World Library (OWL)…

3 weeks ago

Klotho Neurosciences Moves Forward with Manufacturing Gene Therapy for the Treatment of ALS

NEW YORK, June 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with…

3 weeks ago

Launch of the 2026 PhD Students and Early Career Academics Research Grant Programme

02 July 2025 – The IOC Olympic Studies Centre (OSC) has launched a new edition of the grant programme for PhD Students…

3 weeks ago

IMG Launches First ‘Student Journey Scholarship’ for International Students in the U.S.

INDIANAPOLIS, July 1, 2025 /PRNewswire/ -- IMG (International Medical Group), an award-winning global insurance benefits and assistance services company, is…

3 weeks ago

Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage…

1 month ago

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical…

1 month ago

Positive Late-Breaking Data for Incytes First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025

Data demonstrates the potential for INCA033989 to modify disease by directly inhibiting and eliminating oncogenic mutCALR cells, while sparing healthy…

1 month ago

Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced…

1 month ago